JP2002325853A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002325853A5 JP2002325853A5 JP2002061784A JP2002061784A JP2002325853A5 JP 2002325853 A5 JP2002325853 A5 JP 2002325853A5 JP 2002061784 A JP2002061784 A JP 2002061784A JP 2002061784 A JP2002061784 A JP 2002061784A JP 2002325853 A5 JP2002325853 A5 JP 2002325853A5
- Authority
- JP
- Japan
- Prior art keywords
- acetic acid
- pharmaceutical kit
- kit according
- xanthenone
- photodynamic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ABGYSGBNWQSGJD-UHFFFAOYSA-N 2-(9-oxoxanthen-4-yl)acetic acid Chemical compound O1C2=CC=CC=C2C(=O)C2=C1C(CC(=O)O)=CC=C2 ABGYSGBNWQSGJD-UHFFFAOYSA-N 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000003463 hyperproliferative effect Effects 0.000 claims 2
- UZFPOOOQHWICKY-UHFFFAOYSA-N 3-[13-[1-[1-[8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21,24-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-8-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid Chemical compound N1C(C=C2C(=C(CCC(O)=O)C(C=C3C(=C(C)C(C=C4N5)=N3)CCC(O)=O)=N2)C)=C(C)C(C(C)O)=C1C=C5C(C)=C4C(C)OC(C)C1=C(N2)C=C(N3)C(C)=C(C(O)C)C3=CC(C(C)=C3CCC(O)=O)=NC3=CC(C(CCC(O)=O)=C3C)=NC3=CC2=C1C UZFPOOOQHWICKY-UHFFFAOYSA-N 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 229960004293 porfimer sodium Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- XGOYIMQSIKSOBS-UHFFFAOYSA-N vadimezan Chemical compound C1=CC=C2C(=O)C3=CC=C(C)C(C)=C3OC2=C1CC(O)=O XGOYIMQSIKSOBS-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/801,163 US6495585B2 (en) | 2001-03-07 | 2001-03-07 | Method for treating hyperproliferative tissue in a mammal |
| US09/801163 | 2001-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002325853A JP2002325853A (ja) | 2002-11-12 |
| JP2002325853A5 true JP2002325853A5 (cg-RX-API-DMAC7.html) | 2005-09-02 |
Family
ID=25180358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002061784A Pending JP2002325853A (ja) | 2001-03-07 | 2002-03-07 | 哺乳類の過剰増殖組織を処理するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6495585B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1238666B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002325853A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE295163T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60204067T2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE38994E1 (en) | 1988-07-20 | 2006-02-28 | Health Research, Inc. | Pyropheophorbides conjugates and their use in photodynamic therapy |
| USRE39094E1 (en) | 1988-07-20 | 2006-05-09 | Health Research, Inc. | Pyropheophorbides and their use in photodynamic therapy |
| US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
| JP2002534483A (ja) * | 1999-01-15 | 2002-10-15 | ライト サイエンシーズ コーポレイション | 代謝性骨障害または骨転移のための治療的組成物 |
| US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| US7166719B2 (en) | 2002-06-27 | 2007-01-23 | Health Research, Inc. | Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
| US20020049247A1 (en) | 2000-01-12 | 2002-04-25 | Chen James C. | Novel treatment for eye disease |
| AU2003249742A1 (en) | 2002-07-02 | 2004-01-23 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
| WO2008147445A2 (en) * | 2006-11-09 | 2008-12-04 | University Of Maryland, Baltimore | Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent |
| US8180444B2 (en) * | 2007-06-22 | 2012-05-15 | Biolitec Pharma Marketing Ltd | Enhanced PhotoDynamic Therapy with immune system assist |
| US20110201678A1 (en) * | 2008-10-17 | 2011-08-18 | Masse Craig E | Xanthenone-4-Acetic Acid Derivatives |
| CN109289048B (zh) * | 2018-08-08 | 2021-05-25 | 南京工业大学 | 一种肿瘤血管阻断协同光治疗试剂及其合成方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| GB9308166D0 (en) * | 1993-04-20 | 1993-06-02 | Cancer Res Campaign Tech | Cancer therapy |
-
2001
- 2001-03-07 US US09/801,163 patent/US6495585B2/en not_active Expired - Fee Related
-
2002
- 2002-02-28 EP EP02004592A patent/EP1238666B1/en not_active Expired - Lifetime
- 2002-02-28 DE DE60204067T patent/DE60204067T2/de not_active Expired - Fee Related
- 2002-02-28 AT AT02004592T patent/ATE295163T1/de not_active IP Right Cessation
- 2002-03-07 JP JP2002061784A patent/JP2002325853A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002325853A5 (cg-RX-API-DMAC7.html) | ||
| DE60233140D1 (de) | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren | |
| JP2004504382A5 (cg-RX-API-DMAC7.html) | ||
| JP2006502236A5 (cg-RX-API-DMAC7.html) | ||
| CY1112049T1 (el) | Χρηση ανθρακικου λανθανιου για την προληψη της νεφρικης λιθιασικης νοσου | |
| WO2006060809A3 (en) | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | |
| JP2004502684A5 (cg-RX-API-DMAC7.html) | ||
| CA2339384A1 (en) | Improved method for targeted topical treatment of disease | |
| NO995431D0 (no) | Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse | |
| EA200401303A1 (ru) | Лекарственные средства, содержащие стероиды и новое антихолинергическое средство | |
| EP1238666A3 (en) | Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders | |
| JP2004528294A5 (cg-RX-API-DMAC7.html) | ||
| JPH09235233A5 (cg-RX-API-DMAC7.html) | ||
| WO1998041649A3 (en) | Rapid method of cancer diagnosis | |
| IL155578A0 (en) | Novel ascorbic acid compounds, methods of synthesis and application use thereof | |
| JP2005525397A5 (cg-RX-API-DMAC7.html) | ||
| ATE317263T1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
| RU2000108978A (ru) | Способ лечения гастродуоденальных язв, осложненных рубцовоязвенным стенозом верхних отделов желудочно-кишечного тракта | |
| DE69732230D1 (de) | Durch lymphe absorbierbare imidazolderivate | |
| WO2001040234A1 (en) | Porphyrin compound | |
| RU2003108472A (ru) | Средство ранней патогенетической терапии острой лучевой болезни | |
| WO2000073274A3 (de) | Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren | |
| ATE516038T1 (de) | Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen | |
| RU99113773A (ru) | Способ лечения ожогового шока | |
| RU2003128321A (ru) | Способ подавления опухолевого роста |